世界のコンパニオン診断市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP01155)
◆英語タイトル:Global Companion Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP01155
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、コンパニオン診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。コンパニオン診断の種類別市場規模(アッセイキット、試薬)、用途別市場規模(製薬・バイオ製薬会社、研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Abbott Laboratories、Thermo Fisher Scientific、Illumina、Agilent Technologies、Roche、Danaher、Novartis、Qiagen、Myriad Genetics、Sysmex
・地域別グローバル市場分析 2015年-2020年
・コンパニオン診断の北米市場(アメリカ、カナダ、メキシコ)
・コンパニオン診断のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・コンパニオン診断のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・コンパニオン診断の南米市場(ブラジル、アルゼンチン)
・コンパニオン診断の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アッセイキット、試薬
・用途別分析:製薬・バイオ製薬会社、研究所、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Companion Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 19.4% in the forecast period of 2020 to 2025 and will expected to reach USD 18430 million by 2025, from USD 9075.3 million in 2019.

The Companion Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Companion Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Companion Diagnostic market has been segmented into:
Assay Kits
Reagents

By Application, Companion Diagnostic has been segmented into:
Pharmaceutical & Biopharmaceutical Companies
Laboratories
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic market.

The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Companion Diagnostic Market Share Analysis
Companion Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic sales, revenue and market share for each player covered in this report.

The major players covered in Companion Diagnostic are:
Abbott Laboratories
Thermo Fisher Scientific
Illumina
Agilent Technologies
Roche
Danaher
Novartis
Qiagen
Myriad Genetics
Sysmex

【レポートの目次】

Table of Contents

1 Companion Diagnostic Market Overview
1.1 Product Overview and Scope of Companion Diagnostic
1.2 Classification of Companion Diagnostic by Type
1.2.1 Global Companion Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Revenue Market Share by Type in 2019
1.2.3 Assay Kits
1.2.4 Reagents
1.3 Global Companion Diagnostic Market by Application
1.3.1 Overview: Global Companion Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Laboratories
1.3.4 Other
1.4 Global Companion Diagnostic Market by Regions
1.4.1 Global Companion Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina SWOT Analysis
2.3.4 Illumina Product and Services
2.3.5 Illumina Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agilent Technologies SWOT Analysis
2.4.4 Agilent Technologies Product and Services
2.4.5 Agilent Technologies Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Danaher SWOT Analysis
2.6.4 Danaher Product and Services
2.6.5 Danaher Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Qiagen SWOT Analysis
2.8.4 Qiagen Product and Services
2.8.5 Qiagen Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Myriad Genetics
2.9.1 Myriad Genetics Details
2.9.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Myriad Genetics SWOT Analysis
2.9.4 Myriad Genetics Product and Services
2.9.5 Myriad Genetics Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sysmex SWOT Analysis
2.10.4 Sysmex Product and Services
2.10.5 Sysmex Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Players Market Share
3.2.2 Top 10 Companion Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Revenue by Countries
5.1 North America Companion Diagnostic Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Revenue by Countries
6.1 Europe Companion Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Revenue by Countries
8.1 South America Companion Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic by Countries
9.1 Middle East & Africa Companion Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Market Forecast by Type (2019-2024)
10.3 Assay Kits Revenue Growth Rate (2015-2025)
10.4 Reagents Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Market Segment by Application
11.1 Global Companion Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Market Forecast by Application (2019-2024)
11.3 Pharmaceutical & Biopharmaceutical Companies Revenue Growth (2015-2020)
11.4 Laboratories Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Companion Diagnostic Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Abbott Laboratories、Thermo Fisher Scientific、Illumina、Agilent Technologies、Roche、Danaher、Novartis、Qiagen、Myriad Genetics、Sysmex

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のコンパニオン診断市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Companion Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。